eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
3/2017
vol. 68
 
Share:
Share:
more
 
 
abstract:
Case report

EWSR1-fusion-negative, SMARCB1-deficient primary pulmonary myxoid sarcoma

Abbas Agaimy, Thomas Duell, Alicia T. Morresi-Hauf

Pol J Pathol 2017; 68 (3): 261-267
Online publish date: 2017/11/30
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Primary pulmonary myxoid sarcoma (PPMS) is a recently defined rare neoplasm with histological and molecular similarity to extraskeletal myxoid chondrosarcoma. To date, 20 cases have been reported. A 48-year-old man presented with a huge mass filling the right hemithorax and extending into the tracheobronchial system. Histological findings were consistent with PPMS. Immunohistochemistry was positive for vimentin, CD10, and EMA, but other lineage-specific markers were negative. SMARCB1 (INI1) expression was lost in the tumour cells. FISH analysis (EWSR1, FUS, NR4A3, and SMARCB1) revealed no abnormalities. This case suggests SMARCB1 loss as a possible alternative molecular event driving EWSR1-negative PPMS.
keywords:

primary pulmonary myxoid sarcoma, EWSR1, myoepithelial carcinoma, SMARCB1, endobronchial tumour

references:
Nicholson AG, Baandrup U, Florio R, et al. Malignant myxoid endobronchial tumour: a report of two cases with a unique histological pattern. Histopathology 1999; 35: 313-318.
Thway K, Nicholson AG, Lawson K, et al. Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a new tumor entity. Am J Surg Pathol 2011; 35: 1722-1732.
Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG eds. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. 4th ed. IARC Press, Lyon 2015.
Inayama Y, Hayashi H, Ogawa N, et al. Low-grade pulmonary myxoid sarcoma of uncertain histogenesis. Pathol Int 2001; 51: 204-210.
Zhou Q, Lu G, Liu A, et al. Extraskeletal myxoid chondrosarcoma in the lung: asymptomatic lung mass with severe anemia. Diagn Pathol 2012; 7: 112.
Matsukuma S, Hisaoka M, Obara K, et al. Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion, resembling extraskeletal myxoid chondrosarcoma: Case report with a review of literature. Pathol Int 2012; 62: 817-822.
Smith SC, Palanisamy N, Betz BL, et al. At the intersection of primary pulmonary myxoid sarcoma and pulmonary angiomatoid fibrous histiocytoma: observations from three new cases. Histopathology 2014; 65: 144-146.
Jeon YK, Moon KC, Park SH, et al. Primary pulmonary myxoid sarcomas with EWSR1-CREB1 translocation might originate from primitive peribronchial mesenchymal cells undergoing (myo)fibroblastic differentiation. Virchows Arch 2014; 465: 453-461.
Lucas DR, Stenman G. Extraskeletal Myxoid Chondrosarcoma. In: Fletcher CDM, Bridge JA, Hogendoorn CW and Mertens F (eds.). WHO Classification of tumors of soft tissue and bone. (Herndon, VA: Stylus Publishing) 2013; 223-224.
Thway K, Nicholson AG, Wallace WA, et al. Endobronchial pulmonary angiomatoid fibrous histiocytoma: two cases with EWSR1-CREB1 and EWSR1-ATF1 fusions. Am J Surg Pathol 2012; 36: 883-888.
Schaefer IM, Fletcher CD. Myxoid variant of so-called angiomatoid “malignant fibrous histiocytoma”: clinicopathologic characterization in a series of 21 cases. Am J Surg Pathol 2014; 38: 816-823.
Jo VY, Fletcher CD. Myoepithelial neoplasms of soft tissue: an updated review of the clinicopathologic, immunophenotypic, and genetic features. Head Neck Pathol 2015; 9: 32-38.
Falk N, Weissferdt A, Kalhor N, et al. Primary Pulmonary Salivary Gland-type Tumors: A Review and Update. Adv Anat Pathol. 2016; 23: 13-23.
Kalhor N, Suster S, Moran CA. Primary pulmonary chondrosarcomas: a clinicopathologic study of 4 cases. Hum Pathol 2011; 42: 1629-1634.
Herpel E, Rieker RJ, Dienemann H, et al. SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens. Ann Diagn Pathol 26; 2017: 47-51.
Agaimy A. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity. Adv Anat Pathol 2014; 21: 394-410.
FEATURED PRODUCTS
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe